Clinical Trials Directory

Trials / Completed

CompletedNCT05242913

Effects of Resistant Potato Starch on the Gut Microbiota

A Randomized Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Effects of Resistant Potato Starch (SolnulTM) on Intestinal Flora

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
75 (actual)
Sponsor
MSP Starch Products Inc. · Industry
Sex
All
Age
18 Years – 69 Years
Healthy volunteers
Accepted

Summary

This was a randomized, double-blind, three-arm, parallel group clinical trial, which assessed the shifts that occur in microbial populations after four weeks of supplementation with resistant potato starch (SolnulTM) at two different dosages, in comparison to a placebo in healthy adults.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTResistant Potato StarchUnmodified potato starch containing \>60% resistant starch Type 2
DIETARY_SUPPLEMENTPlaceboFully digestible corn starch

Timeline

Start date
2019-10-30
Primary completion
2020-01-06
Completion
2020-01-06
First posted
2022-02-16
Last updated
2022-02-16

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05242913. Inclusion in this directory is not an endorsement.